TY - JOUR T1 - Estimation of the COVID-19 Average Incubation Time: Systematic Review, Meta-analysis and Sensitivity Analyses JF - medRxiv DO - 10.1101/2022.01.17.22269421 SP - 2022.01.17.22269421 AU - Yijia Weng AU - Grace Y.Yi Y1 - 2022/01/01 UR - http://medrxiv.org/content/early/2022/01/18/2022.01.17.22269421.abstract N2 - Objectives We aim to provide sensible estimates of the average incubation time of COVID-19 by capitalizing available estimates reported in the literature and explore different ways to accommodate heterogeneity involved with the reported studies.Methods We search through online databases to collect the studies about estimates of the average incubation time and conduct meta-analyses to accommodate heterogeneity of the studies and the publication bias. Cochran’s heterogeneity statistic Q and Higgin’s & Thompson’s I2 statistic are employed. Subgroup analyses are conducted using mixed effects models and publication bias is assessed using the funnel plot and Egger’s test.Results Using all those reported mean incubation estimates, the average incubation time is estimated to be 6.43 days with a 95% confidence interval (CI) (5.90, 6.96), and using all those reported mean incubation estimates together with those transformed median incubation estimates, the estimated average incubation time is 6.07 days with a 95% CI (5.70,6.45).Conclusions Providing sensible estimates of the average incubation time for COVID-19 is important yet complex, and the available results vary considerably due to many factors including heterogeneity and publication bias. We take different angles to estimate the mean incubation time, and our analyses provide estimates to range from 5.68 days to 8.30 days.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe research was partially supported by the grants of the Discovery Grants Program and the Emerging Infectious Disease Modeling Program from the Natural Sciences and Engineering Research Council of Canada. Yi is Canada Research Chair in Data Science (Tier 1). Her research was undertaken, in part, thanks to funding from the Canada Research Chairs program.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The data is obtained from gathering reported pooled results from a range of public published papers since the article is about meta-analysis. Data can be obtained from google scholar and similar platforms by searching the citation for these papers.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript. ER -